Gutknecht, Mandy http://orcid.org/0000-0003-0835-6258
Schaarschmidt, Marthe-Lisa
Danner, Marion
Otten, Marina
Augustin, Matthias
Article History
Received: 8 February 2018
Revised: 17 May 2018
Accepted: 14 June 2018
First Online: 23 June 2018
Compliance with ethical standards
:
: M. Gutknecht received financial support for participation in conferences from AbbVie and obtained honoraria from Novartis. M.-L. Schaarschmidt conducted clinical trials for AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Janssen-Cilag, Merck, Novartis and UCB Pharma; obtained honoraria from Janssen-Cilag and Novartis; and received financial support for participation in conferences from AbbVie, ALK-Abello, Biogen Inc., Janssen-Cilag and MSD. M. Danner has no conflict of interest. M. Otten received financial support for participation in conferences from Celgene. M. Augustin has served as consultant and/or paid speaker for and/or has received research grants and/or honoraria for consulting and/or scientific lectures for and/or got travel expenses reimbursed and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including AbbVie, Almirall, Amgen, Biogen Idec, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Janssen-Cilag, Leo, Medac, MSD (formerly Essex, Schering-Plough), Mundipharma, Novartis, Pfizer (formerly Wyeth), Pohl Boskamp, Sandoz and Xenoport.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.